Virtual Reality Distraction During Arteriovenous Fistula Puncture

February 17, 2023 updated by: mohamed elsayed hamed elzeky, Mansoura University

The Effect of Virtual Reality Distraction on Pain and Anxiety During Arteriovenous Fistula Puncture Among Hemodialysis Patients: Randomized Controlled Trial

The cannulation of arteriovenous fistula is a painful procedure in hemodialysis patients. Previous studies have shown the effectiveness of virtual reality in reducing pain during needle-related procedures

Study Overview

Status

Completed

Detailed Description

Patients undergoing hemodialysis experience anxiety and pain related to the insertion of hemodialysis needles, estimated 320 times in total per year. The pain experienced is mostly caused by needle insertion into a fistula. Pain control is one of the main nursing tasks. Pain relief leads to the acceptance of the procedure and ultimately enhances the patients' quality of life. The use of virtual reality to reduce pain and anxiety during the arteriovenous fistula cannulation procedure is based on the concept that the perception of pain can be controlled because an individual is able to process only a limited amount of information at once. As such, the use of virtual reality during painful procedures may serve as a distraction.

Study Type

Interventional

Enrollment (Actual)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mansoura, Egypt
        • faculty of nursing Mansoura university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients who are under- going conventional hemodialysis three times a week
  • hemodialysis period of one month or more
  • having a healthy AVF access with good function
  • welling to participate in study

Exclusion Criteria:

  • patients who have psychiatric diseases
  • panic disorder, anxiety disorder
  • dysfunctional fistula
  • vertigo, issues with sight, hearing, or perception
  • or use painkillers within three hours before hemodialysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Experimental: study group
study group patients will view VR scene for 6 minutes before puncture .It involves a soothing nature experience and calming background music. Patients in intervention group will not able to see the puncture procedure due to the VR glasses.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in patients pain scores
Time Frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
visual analogue scale which consists of a vertical line 100 mm long, one end of the line reads "No pain" and at the other is "Unbearable pain
will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
change in patients anxiety scores
Time Frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
STAI includes two subscales with 20 items each that assess state and trait anxiety .The State Anxiety Scale requires individuals to describe their feelings at a specific moment under specific circumstances, while the Trait Anxiety Scale requires them to describe the way they feel in general.
will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in patients satisfaction score
Time Frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
. The patients will be asked to rate procedure satisfaction placing a mark on a 100-mm vertical visual analogue scale
will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
change in patients heart rate
Time Frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
checklist will be used to assess heart rate after puncture
will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
change in patients respiratory rate
Time Frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
checklist will be used to assess respiratory rate after puncture
will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
change in patients systolic blood pressure
Time Frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
checklist will be used to assess systolic blood pressure after puncture
will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
change in patients diastolic blood pressure
Time Frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
checklist will be used to assess diastolic blood pressure after puncture
will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
change in patients Oxygen saturation (SpO2)
Time Frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)
checklist will be used to assess Oxygen saturation after puncture
will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2022

Primary Completion (Actual)

November 30, 2022

Study Completion (Actual)

February 15, 2023

Study Registration Dates

First Submitted

May 22, 2022

First Submitted That Met QC Criteria

May 26, 2022

First Posted (Actual)

June 1, 2022

Study Record Updates

Last Update Posted (Estimate)

February 21, 2023

Last Update Submitted That Met QC Criteria

February 17, 2023

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis

Clinical Trials on virtual reality distraction

Subscribe